Observational studyInternational journal of epidemiology2017
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.
Abstract readObservational Study
In one paragraph
Observational study in International journal of epidemiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
81 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature.Blood advances · 2024Pooled it
- Trial
- Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.Blood cancer journal · 2020Trial
- Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma.British journal of haematology · 2019Trial
- Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019Trial
- The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas.American journal of hematology · 2019Trial
- A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.Blood · 2018Trial
- The Baseline Molecular Profile of Late Relapse: Identifying Drivers of Delayed Recurrence in DLBCL.Hematological oncology · 2026Article
- No Association of Prior Administration of Selected Vaccines with Lymphoma Prognosis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.American journal of hematology · 2026Article
- High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes.American journal of hematology · 2026Article
- Functional evaluation of TRPC6 missense variants in cancer patients via molecular docking analysis compared with patch Clamp electrophysiology.The Journal of biological chemistry · 2026Article
- Patterns of care and clinical outcomes in systemic peripheral T-cell lymphoma: the LEO-MER prospective cohort study.Blood advances · 2026Observational
- Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes.British journal of haematology · 2026Article
- FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026Article
- Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapy.Blood cancer journal · 2026Article
- Functional Evaluation ofbioRxiv : the preprint server for biology · 2026Article
- Development and validation of a gene expression signature to predict early events in patients with follicular lymphoma.Blood advances · 2025Article
- An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma.NEJM evidence · 2025Article
- Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts.Blood cancer journal · 2025Article
21 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
James R CerhanDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Brian K LinkDepartment of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Thomas M HabermannDepartment of Medicine.
Matthew J MaurerDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Andrew L FeldmanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Sergei I SyrbuDepartment of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Carrie A ThompsonDepartment of Medicine.
Umar FarooqDepartment of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Anne J NovakDepartment of Medicine.
Susan L SlagerDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Cristine AllmerDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Julianne J LundeDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
William R MaconDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
David J InwardsDepartment of Medicine.
Patrick B JohnstonDepartment of Medicine.
Ivana N M MicallefDepartment of Medicine.
Grzegorz S NowakowskiDepartment of Medicine.
Stephen M AnsellDepartment of Medicine.
Neil E KayDepartment of Medicine.
George J WeinerDepartment of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Thomas E WitzigDepartment of Medicine.
Funding
Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3MViral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0MThe Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI LENTZ, STEVEN R · 2002 to 2021
$45.7MThe Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)U01CA195568 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R, FLOWERS, CHRISTOPHER R · 2015 to 2025
$22.1MMolecular Epidemiology of NHL and CLLR01CA092153 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R · 2003 to 2012
$6.7MGenetic Epidemiology of non-Hodgkin LymphomaR01CA200703 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R · 2016 to 2020
$3.3MGenetic Biomarkers for Risk Assessment of Peripheral T-Cell LymphomasR01CA177734 · NCI · MAYO CLINIC ROCHESTER · PI FELDMAN, ANDREW LEWIS · 2013 to 2017
$1.6MMolecular Epidemiology of non-Hodgkin Lymphoma SurvivalR01CA129539 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R · 2009 to 2010
$1.2MCSRD VA I01 CX000821NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA097274NCI NIH HHS R01 CA092153NCI NIH HHS R01 CA129539NCI NIH HHS R01 CA177734NCI NIH HHS R01 CA200703NCI NIH HHS U01 CA195568
Abstract
PubMed holds no abstract for this paper.
Indexed as
Molecular EpidemiologyAdultAgedCohort StudiesHumansLymphomaMiddle AgedPatient Reported Outcome MeasuresProspective StudiesRegistriesSurvival AnalysisTreatment OutcomeUnited States
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.